Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company SurgiMab S.A.S.
DescriptionTumor-specific fluorescent injectable conjugate for intra-operative fluorescence guidance
Molecular Target
Mechanism of ActionImaging agent
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPhase I/II
Standard IndicationCancer, Diagnostic
Indication DetailsImaging agent for CEA-expressing cancers during surgery; Imaging agent for pancreatic or rectal cancer; Imaging agent for peritoneal carcinomatosis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today